Psychiatrically hospitalized children: a critical review.

por Scahill, L., Riddle, M. A.
Publicado 1990

Sewage Disposal and Wildlife Health in Antarctica

por Smith, J. J., Riddle, M. J.
Publicado 2008

Fasting plasma glucose 6–12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis

por Karl, D, Zhou, R, Vlajnic, A, Riddle, M
Publicado 2012

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ s...

por Owens, D R, Luzio, S D, Sert-Langeron, C, Riddle, M C
Publicado 2011

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized c...

por Matsuhisa, M., Koyama, M., Cheng, X., Takahashi, Y., Riddle, M. C., Bolli, G. B., Hirose, T.
Publicado 2016

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycae...

por Terauchi, Y., Koyama, M., Cheng, X., Takahashi, Y., Riddle, M. C., Bolli, G. B., Hirose, T.
Publicado 2016

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)...

por Bolli, G B, Riddle, M C, Bergenstal, R M, Ziemen, M, Sestakauskas, K, Goyeau, H, Home, P D
Publicado 2015

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insu...

por Riddle, M C, Yki-Järvinen, H, Bolli, G B, Ziemen, M, Muehlen-Bartmer, I, Cissokho, S, Home, P D
Publicado 2015

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

por Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J. P., Hramiak, I., Johnston, P., Davis, M.
Publicado 2009

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label...

por Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J.-P., Hramiak, I., Johnston, P., Davis, M.
Publicado 2009

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label...

por Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J.-P., Hramiak, I., Johnston, P., Davis, M.
Publicado 2009

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes

por Riddle, M. C., Yuen, K. C. J., de Bruin, T. W., Herrmann, K., Xu, J., Öhman, P., Kolterman, O. G.
Publicado 2015

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaem...

por Yki‐Järvinen, H., Bergenstal, R. M., Bolli, G. B., Ziemen, M., Wardecki, M., Muehlen‐Bartmer, I., Maroccia, M., Riddle, M. C.
Publicado 2015

Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabe...

por Home, P D, Bolli, G B, Mathieu, C, Deerochanawong, C, Landgraf, W, Candelas, C, Pilorget, V, Dain, M-P, Riddle, M C
Publicado 2015

Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28–29th November 2018

por Prudden, H.J., Hasso-Agopsowicz, M., Black, R.E., Troeger, C., Reiner, R.C., Breiman, R.F., Jit, M., Kang, G., Lamberti, L., Lanata, C.F., Lopman, B.A., Ndifon, W., Pitzer, V.E., Platts-Mills, J.A., Riddle, M.S., Smith, P.G., Hutubessy, R., Giersing, B.
Publicado 2020